Royalty Pharma plcRPRXNASDAQ
LOADING
|||
Price to Sales: Discounted Valuation
Below historical average, structural decline.
Left:
||||
Price-to-sales ratio
Latest
5.03
↓ 46% below average
Average (9y)
9.25
Historical baseline
Range
High:16.35
Low:5.03
CAGR
-12.3%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | 5.03 | -5.9% |
| 2023 | 5.34 | -31.0% |
| 2022 | 7.74 | +7.2% |
| 2021 | 7.22 | -21.1% |
| 2020 | 9.15 | +5.4% |
| 2019 | 8.69 | -1.1% |
| 2018 | 8.78 | -11.0% |
| 2017 | 9.86 | -31.5% |
| 2016 | 14.39 | -12.0% |
| 2015 | 16.35 | - |